Literature DB >> 15514379

Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.

Thomas K Eigentler1, Petra G Buettner, Ulrike Leiter, Claus Garbe.   

Abstract

PURPOSE: In 2001, the new American Joint Committee on Cancer classification of cutaneous melanoma (CM) introduced ulceration of the primary melanoma as a new key parameter being represented in respective subcategories of the tumor (T) classification. The present study was performed to validate the prognostic significance of ulceration in relation to T thickness and clinical stages of CM (stages I to III). PATIENTS AND METHODS: Patients (N = 15,158) with incident invasive primary nonmetastatic CM and follow-up data recorded between 1976 and 2000 by the German Central Malignant Melanoma Registry were investigated using survival analysis to evaluate prognostic factors such as T thickness, level of invasion, body site, histologic subtype, ulceration, regression, age, and sex.
RESULTS: Comparisons of survival probabilities according to the Kaplan-Meier method between ulcerated and nonulcerated CM were not statistically significant for subgroups with T thickness < or = 1 mm and more than 4.00 mm (P = .2601 and P = .0699, respectively) but were significant for T thickness of 1.01 to 2.00 mm and 2.01 to 4.00 mm (P < .0001 for both). This result was confirmed in the multivariate analysis. For stage III CM, the impact of ulceration on overall survival was statistically significant in the bivariate Cox model (P = .0111) but not in the multivariate Cox model (P = .0522).
CONCLUSION: Whereas ulceration seems to have a negative impact on the prognosis of patients with stages T2 and T3, a potential influence for patients with stages T1 and T4 could not be established. If factors of the primary CM were to be taken into consideration to judge prognosis of stage III CM, T thickness but not ulceration should be the focus.

Entities:  

Mesh:

Year:  2004        PMID: 15514379     DOI: 10.1200/JCO.2004.03.075

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  7 in total

1.  Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

Authors:  Ellen H de Moll; Yichun Fu; Yingzhi Qian; Sara H Perkins; Shira Wieder; Sacha Gnjatic; Romain Remark; Sebastian G Bernardo; Marina Moskalenko; Jonathan Yao; Tammie Ferringer; Rui Chang; Jerry Chipuk; Basil A Horst; Miriam B Birge; Robert G Phelps; Yvonne M Saenger
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

Review 2.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

3.  The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.

Authors:  Le-Bin Song; Jiao-Chen Luan; Qi-Jie Zhang; Lin Chen; Hao-Yang Wang; Xue-Chen Cao; Ning-Hong Song; Yan Lu
Journal:  J Immunol Res       Date:  2021-02-19       Impact factor: 4.818

4.  Subtyping Cutaneous Melanoma Matters.

Authors:  Mary-Ann El Sharouni; Paul Johannes van Diest; Arjen Joost Witkamp; Vigfús Sigurdsson; Carla Henrica van Gils
Journal:  JNCI Cancer Spectr       Date:  2020-10-23

5.  Sentinel lymph node biopsy for cutaneous melanoma: a 6 years study.

Authors:  Jaime Lima Sánchez; M Sánchez Medina; O García Duque; M Fiúza Pérez; G Carreteri Hernández; J Fernández Palácios
Journal:  Indian J Plast Surg       Date:  2013-01

6.  Prognostic factors for metastasis in cutaneous melanoma.

Authors:  Ana Carolina Figueiredo Pereira Cherobin; Alberto Julius Alves Wainstein; Enrico Antônio Colosimo; Eugênio Marcos Andrade Goulart; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

7.  Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.

Authors:  Xiaoting Wei; Di Wu; Yu Chen; Hang Li; Rui Zhang; Hong Yao; Zhihong Chi; Chuanliang Cui; Xue Bai; Lili Mao; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xuan Wang; Jun Guo; Lu Si
Journal:  Br J Dermatol       Date:  2022-03-25       Impact factor: 11.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.